123 related articles for article (PubMed ID: 19239259)
1. Octahydrophenanthrene-2,7-diol analogues as dissociated glucocorticoid receptor agonists: discovery and lead exploration.
Robinson RP; Buckbinder L; Haugeto AI; McNiff PA; Millham ML; Reese MR; Schaefer JF; Abramov YA; Bordner J; Chantigny YA; Kleinman EF; Laird ER; Morgan BP; Murray JC; Salter ED; Wessel MD; Yocum SA
J Med Chem; 2009 Mar; 52(6):1731-43. PubMed ID: 19239259
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel dihydro-9,10-ethano-anthracene carboxamides as glucocorticoid receptor modulators.
Yang BV; Vaccaro W; Doweyko AM; Doweyko LM; Huynh T; Tortolani D; Nadler SG; McKay L; Somerville J; Holloway DA; Habte S; Weinstein DS; Barrish JC
Bioorg Med Chem Lett; 2009 Apr; 19(8):2139-43. PubMed ID: 19321341
[TBL] [Abstract][Full Text] [Related]
3. 2-Aryl-3-methyloctahydrophenanthrene-2,3,7-triols as potent dissociated glucocorticoid receptor agonists.
Chantigny YA; Murray JC; Kleinman EF; Robinson RP; Plotkin MA; Reese MR; Buckbinder L; McNiff PA; Millham ML; Schaefer JF; Abramov YA; Bordner J
J Med Chem; 2015 Mar; 58(6):2658-77. PubMed ID: 25706100
[TBL] [Abstract][Full Text] [Related]
4. Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series.
Barker M; Clackers M; Copley R; Demaine DA; Humphreys D; Inglis GG; Johnston MJ; Jones HT; Haase MV; House D; Loiseau R; Nisbet L; Pacquet F; Skone PA; Shanahan SE; Tape D; Vinader VM; Washington M; Uings I; Upton R; McLay IM; Macdonald SJ
J Med Chem; 2006 Jul; 49(14):4216-31. PubMed ID: 16821781
[TBL] [Abstract][Full Text] [Related]
5. Non-steroidal glucocorticoid agonists: the discovery of aryl pyrazoles as A-ring mimetics.
Clackers M; Coe DM; Demaine DA; Hardy GW; Humphreys D; Inglis GG; Johnston MJ; Jones HT; House D; Loiseau R; Minick DJ; Skone PA; Uings I; McLay IM; Macdonald SJ
Bioorg Med Chem Lett; 2007 Sep; 17(17):4737-45. PubMed ID: 17616395
[TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivity.
Biggadike K; Boudjelal M; Clackers M; Coe DM; Demaine DA; Hardy GW; Humphreys D; Inglis GG; Johnston MJ; Jones HT; House D; Loiseau R; Needham D; Skone PA; Uings I; Veitch G; Weingarten GG; McLay IM; Macdonald SJ
J Med Chem; 2007 Dec; 50(26):6519-34. PubMed ID: 18038970
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonists.
Sheppeck JE; Gilmore JL; Xiao HY; Dhar TG; Nirschl D; Doweyko AM; Sack JS; Corbett MJ; Malley MF; Gougoutas JZ; Mckay L; Cunningham MD; Habte SF; Dodd JH; Nadler SG; Somerville JE; Barrish JC
Bioorg Med Chem Lett; 2013 Oct; 23(19):5442-7. PubMed ID: 23953070
[TBL] [Abstract][Full Text] [Related]
8. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
Schäcke H; Berger M; Rehwinkel H; Asadullah K
Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore.
Razavi H; Riether D; Harcken C; Bentzien J; Dinallo RM; Souza D; Nelson RM; Kukulka A; Fadra-Khan TN; Pack EJ; Zuvela-Jelaska L; Pelletier J; Panzenbeck M; Torcellini CA; Proudfoot JR; Nabozny GH; Thomson DS
Bioorg Med Chem Lett; 2014 Apr; 24(8):1934-40. PubMed ID: 24656565
[TBL] [Abstract][Full Text] [Related]
10. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
[TBL] [Abstract][Full Text] [Related]
11. The first X-ray crystal structure of the glucocorticoid receptor bound to a non-steroidal agonist.
Madauss KP; Bledsoe RK; Mclay I; Stewart EL; Uings IJ; Weingarten G; Williams SP
Bioorg Med Chem Lett; 2008 Dec; 18(23):6097-9. PubMed ID: 18952422
[TBL] [Abstract][Full Text] [Related]
12. Trifluoromethyl group as a pharmacophore: effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand.
Betageri R; Zhang Y; Zindell RM; Kuzmich D; Kirrane TM; Bentzien J; Cardozo M; Capolino AJ; Fadra TN; Nelson RM; Paw Z; Shih DT; Shih CK; Zuvela-Jelaska L; Nabozny G; Thomson DS
Bioorg Med Chem Lett; 2005 Nov; 15(21):4761-9. PubMed ID: 16112571
[TBL] [Abstract][Full Text] [Related]
13. Discovery and SAR study of novel dihydroquinoline-containing glucocorticoid receptor agonists.
Takahashi H; Bekkali Y; Capolino AJ; Gilmore T; Goldrick SE; Kaplita PV; Liu L; Nelson RM; Terenzio D; Wang J; Zuvela-Jelaska L; Proudfoot J; Nabozny G; Thomson D
Bioorg Med Chem Lett; 2007 Sep; 17(18):5091-5. PubMed ID: 17681466
[TBL] [Abstract][Full Text] [Related]
14. Discovery of quinolines as selective glucocorticoid receptor agonists.
Jaroch S; Berger M; Huwe C; Krolikiewicz K; Rehwinkel H; Schäcke H; Schmees N; Skuballa W
Bioorg Med Chem Lett; 2010 Oct; 20(19):5835-8. PubMed ID: 20727743
[TBL] [Abstract][Full Text] [Related]
15. Identification of dissociated non-steroidal glucocorticoid receptor agonists.
Kuzmich D; Kirrane T; Proudfoot J; Bekkali Y; Zindell R; Beck L; Nelson R; Shih CK; Kukulka AJ; Paw Z; Reilly P; Deleon R; Cardozo M; Nabozny G; Thomson D
Bioorg Med Chem Lett; 2007 Sep; 17(18):5025-31. PubMed ID: 17692519
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal 2,3-dihydroquinoline glucocorticoid receptor agonists with reduced PEPCK activation.
Hudson AR; Higuchi RI; Roach SL; Valdez LJ; Adams ME; Vassar A; Rungta D; Syka PM; Mais DE; Marschke KB; Zhi L
Bioorg Med Chem Lett; 2011 Mar; 21(6):1654-7. PubMed ID: 21324689
[TBL] [Abstract][Full Text] [Related]
17. Dimethyl-diphenyl-propanamide derivatives as nonsteroidal dissociated glucocorticoid receptor agonists.
Yang BV; Weinstein DS; Doweyko LM; Gong H; Vaccaro W; Huynh T; Xiao HY; Doweyko AM; McKay L; Holloway DA; Somerville JE; Habte S; Cunningham M; McMahon M; Townsend R; Shuster D; Dodd JH; Nadler SG; Barrish JC
J Med Chem; 2010 Dec; 53(23):8241-51. PubMed ID: 21073190
[TBL] [Abstract][Full Text] [Related]
18. X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain.
Biggadike K; Bledsoe RK; Hassell AM; Kirk BE; McLay IM; Shewchuk LM; Stewart EL
J Med Chem; 2008 Jun; 51(12):3349-52. PubMed ID: 18522385
[TBL] [Abstract][Full Text] [Related]
19. Non-steroidal dissociated glucocorticoid agonists: indoles as A-ring mimetics and function-regulating pharmacophores.
Betageri R; Gilmore T; Kuzmich D; Kirrane TM; Bentzien J; Wiedenmayer D; Bekkali Y; Regan J; Berry A; Latli B; Kukulka AJ; Fadra TN; Nelson RM; Goldrick S; Zuvela-Jelaska L; Souza D; Pelletier J; Dinallo R; Panzenbeck M; Torcellini C; Lee H; Pack E; Harcken C; Nabozny G; Thomson DS
Bioorg Med Chem Lett; 2011 Nov; 21(22):6842-51. PubMed ID: 21963986
[TBL] [Abstract][Full Text] [Related]
20. Hemisuccinate of 21-hydroxy-6,19-epoxyprogesterone: a tissue-specific modulator of the glucocorticoid receptor.
Alvarez LD; Martí MA; Veleiro AS; Misico RI; Estrin DA; Pecci A; Burton G
ChemMedChem; 2008 Dec; 3(12):1869-77. PubMed ID: 18985652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
